Determination of frail state and association of frailty with inflammatory markers among cardiac surgery patients in a Central European patient population.


Journal

Clinical hemorheology and microcirculation
ISSN: 1875-8622
Titre abrégé: Clin Hemorheol Microcirc
Pays: Netherlands
ID NLM: 9709206

Informations de publication

Date de publication:
2020
Historique:
pubmed: 7 11 2019
medline: 9 2 2021
entrez: 6 11 2019
Statut: ppublish

Résumé

With the aging of the population, the screening of frail patients, especially before high-risk surgery, come to the fore. The background of the frail state is not totally clear, most likely inflammatory processes are involved in the development. Our survey of patients over age of 65 who were on cardiac surgery were performed with Edmonton Frail Scale (EFS). Patients' demographic, perioperative data, incidence of complications and correlations of inflammatory laboratory parameters were studied with the severity of the frail state. On the basis of EFS, 313 patients were divided into non-frail (NF,163,52%), pre-frail (PF,89,28.5%) and frail (F,61,19.5%) groups. Number of complications in the three groups were different (NF:0.67/patient, PF:0.76/patient, F:1.08/patient). We showed significant difference between NF and F in both intensive care and hospital stay, but there was no statistical difference between the groups in hospital deaths (NF:5/163, PF:3/89, F:5/61). We also found a significant difference between NF and F patients in preoperative fibrinogen-, CRP- and white blood cell count levels. We first present the incidence of frailty in patients with heart surgery in a Central-European population. According to our results, inflammatory processes are likely to play a role in the development of the frail state.

Identifiants

pubmed: 31683468
pii: CH190681
doi: 10.3233/CH-190681
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-350

Auteurs

Rudolf Kiss (R)

Heart Institute, Medical School, University of Pécs, Pécs, Hungary, and Szentágothai Research Centre, University of Pécs, Pécs, Hungary.

Nelli Farkas (N)

Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary.

Gabor Jancso (G)

Department of Surgical Research and Techniques, Medical School, University of Pécs, Pécs, Hungary.

Krisztina Kovacs (K)

Department of Biochemistry and Medical Chemistry, Medical School, University of Pécs, Pécs, Hungary.

Laszlo Lenard (L)

Heart Institute, Medical School, University of Pécs, Pécs, Hungary, and Szentágothai Research Centre, University of Pécs, Pécs, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH